Updated Date:
20 Jul 2026
Product Detail:
MOVAPO PFS apomorphine hydrochloride hemihydrate 50mg/10mL solution for subcutaneous infusion pre-filled syringe
Shortage Status:
Discontinued
AUST R:
129948
Availability:
Reduction in supply until supply is exhausted
Active Ingredient:
apomorphine hydrochloride hemihydrate
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Injection,solution
Supply Impact Dates
Management Action:
An alternative presentation is available - MOVAPO POD apomorphine hydrochloride hemihydrate 100 mg/20 mL solution for injection cartridge (ARTG 423350). Patients are advised to consult their healthcare professional to discuss alternative treatment options.